Back to CA Caption Management, LLC

CNTA

6 quarters

Position history for CACaption Management, LLC's holdings in CENTESSA PHARMACEUTICALS PLC

As of its Q1 2026 13F, Caption Management held 274,116 shares of CNTA (Centessa Pharmaceuticals), worth $10.9M. CNTA was 0.1% of Caption Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$315,166

Total Shares Change

-21,917

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$40.50
0
2026-Q1
New
274,116
-
$10.9M0.1%$26.20
38
2025-Q4
Exited
0
-100.0%
$00.0%$24.74
0
2025-Q3
New
125,309
-
$3M0.0%$24.40
37
2025-Q2
Exited
0
-100.0%
$00.0%$13.13
0
2025-Q1
New
21,917
-
$315,1660.0%$14.59
33

Other major holders of CNTA: Avoro Capital Advisors LLC, Adage Capital Partners GP, L.L.C., Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used